Centessa Pharmaceuticals plc — Director's Dealing 2024

Jan 3, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Centessa Pharmaceuticals plc (CNTA)
CIK: 0001847903
Period of Report: 2023-12-31

Reporting Person: HUSSAIN IQBAL J (General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-31	Ordinary Shares	F	7520	$7.96	Disposed	185435	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	5500	Indirect

Footnotes

F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.